Home
OverviewAbout10 LeapsCollaborationImpact
OverviewLeaps TalksChapter FilmsLeaps.orgPartners
AgricultureHealth
OverviewAnnual ReviewBreakthrough StudyPress ReleasesIn the NewsReportsLeaps LeadershipPress KitMedia Contact
Team
  • Approach
    • Overview
    • About
    • 10 Leaps
    • Collaboration
    • Impact
  • Engagement
    • Overview
    • Leaps Talks
    • Chapter Films
    • Leaps.org
    • Partners
    • Agriculture
    • Health
  • News
    • Overview
    • Annual Review
    • Breakthrough Study
    • Press Releases
    • In the News
    • Reports
    • Leaps Leadership
    • Press Kit
    • Media Contact
  • Team
ContactImprintPrivacy StatementConditions of Use
sign up for our newsletter
see more companies

Aferna Bio

Aferna Bio

Vision

Translating cutting-edge biology into commercially relevant crops

Approach

Aferna focuses on utilizing RNA methylation modulation in plants through a class of enzymes to induce significant phenotypic changes, such as increased root biomass and grain size. This innovative approach aims to alter global gene expression, potentially revolutionizing agricultural crop resilience and yield. Aferna is dedicated to translating this groundbreaking science into commercially relevant crops, offering new solutions for enhanced yield and resilience in agriculture.

Aferna Bio is addressing

  • Leap 09 / Prevent crop and food loss

CEO:

Jon Schmuke

Founders:

Leaps by Bayer

Plaisance Capital

Professor Chuan He, John T. Wilson Distinguished Service Professor at University of Chicago and Howard Hughes Medical Investigator, and winner of the 2023 Wolf Prize in Chemistry

First investment:

January 2022

www.afernabio.com